305 related articles for article (PubMed ID: 25712399)
1. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
Umemura E; Sakamoto Y; Takahashi Y; Miyake T
J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
[No Abstract] [Full Text] [Related]
2. Dimeric aminoglycosides as antibiotics.
Agnelli F; Sucheck SJ; Marby KA; Rabuka D; Yao SL; Sears PS; Liang FS; Wong CH
Angew Chem Int Ed Engl; 2004 Mar; 43(12):1562-6. PubMed ID: 15022234
[No Abstract] [Full Text] [Related]
3. Effect of varying the 4''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.
Hiraiwa Y; Minowa N; Usui T; Akiyama Y; Maebashi K; Ikeda D
Bioorg Med Chem Lett; 2007 Nov; 17(22):6369-72. PubMed ID: 17889537
[TBL] [Abstract][Full Text] [Related]
4. Cefoxitin: synergism with aminoglycosides in vitro.
Une T; Osada Y; Ogawa H
Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of 5-deoxy-5-episubstituted arbekacin derivatives.
Hiraiwa Y; Usui T; Akiyama Y; Maebashi K; Minowa N; Ikeda D
Bioorg Med Chem Lett; 2007 Jul; 17(13):3540-3. PubMed ID: 17502146
[TBL] [Abstract][Full Text] [Related]
6. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
7. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
[TBL] [Abstract][Full Text] [Related]
8. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
Coulet M; Brun Y; Forey F; Fleurette J
Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
[TBL] [Abstract][Full Text] [Related]
9. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.
Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1995 Jun; 35(6):865-8. PubMed ID: 7559197
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of dibekacin and gentamicin activities.
Hill CD; Counts GW; Turck M
Antimicrob Agents Chemother; 1981 Jan; 19(1):190-2. PubMed ID: 6787978
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa.
Paradelis AG; Douboyas J; Stathopoulos G; Grigoriadou-Edipides A; Triantaphylidis C; Papapanagiotou J
Antimicrob Agents Chemother; 1978 Sep; 14(3):514-5. PubMed ID: 101135
[TBL] [Abstract][Full Text] [Related]
12. A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Hisamichi K; Mikami T; Watanabe A
J Antimicrob Chemother; 1998 Apr; 41(4):495-7. PubMed ID: 9598784
[No Abstract] [Full Text] [Related]
13. Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
Kumar V; Remers WA
J Med Chem; 1979 Apr; 22(4):432-6. PubMed ID: 107311
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
Klastersky J; Nyamubeya B; Vandenborre L
J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
[No Abstract] [Full Text] [Related]
15. Design and synthesis of pyrankacin: a pyranmycin class of broad-spectrum aminoglycoside antibiotic.
Rai R; Chen HN; Czyryca PG; Li J; Chang CW
Org Lett; 2006 Mar; 8(5):887-9. PubMed ID: 16494466
[TBL] [Abstract][Full Text] [Related]
16. Lithocholic acid and derivatives: Antibacterial activity.
do Nascimento PG; Lemos TL; Almeida MC; de Souza JM; Bizerra AM; Santiago GM; da Costa JG; Coutinho HD
Steroids; 2015 Dec; 104():8-15. PubMed ID: 26216208
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
Kosakai N; Oguri T
Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activities of SCE-129, sulbenicillin, gentamicin, and dibekacin against Pseudomonas.
Tsuchiya K; Kondo M
Antimicrob Agents Chemother; 1978 Mar; 13(3):536-9. PubMed ID: 122528
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
Tsuji A; Sugano T; Yamaguchi K; Goto S; Takada T; Takase Y; Yoshida T
Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
